Edition:
United States

Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

155.00GBp
8 Dec 2016
Change (% chg)

0.00p (+0.00%)
Prev Close
155.00p
Open
155.00p
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,192
52-wk High
255.00p
52-wk Low
78.75p

AKR.L

Chart for AKR.L

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)
No analyst recommendations are available for AKR.L.

Overall

Beta: 1.30
Market Cap(Mil.): £8.02
Shares Outstanding(Mil.): 5.45
Dividend: --
Yield (%): --

Financials

  AKR.L Industry Sector
P/E (TTM): -- 41.98 30.40
EPS (TTM): -1.28 -- --
ROI: -103.73 -0.36 15.24
ROE: -103.73 -0.94 16.58

BRIEF-Akers Biosciences files for potential stock shelf, size not disclosed

* Files for potential stock shelf; size not disclosed - sec filing Source text : http://bit.ly/2fGeOku Further company coverage:

Nov 16 2016

BRIEF-Akers Biosciences reports Q3 earnings

* Akers Biosciences announces Q3 earnings Source text for Eikon: Further company coverage:

Nov 14 2016

BRIEF-Akers Biosciences issued european patent protection for breath ketone detector

* Akers biosciences issued european patent protection for breath ketone detector Source text for Eikon: Further company coverage:

Nov 10 2016

BRIEF-Akers Biosciences settles, to sell breath technology tests

* Settles dispute with Chube, Thirty Six Strategies Llc , Gavin Moran, Frank Runge - SEC Filing

Aug 19 2016

BRIEF-Akers Biosciences Q2 loss before income tax $1 million

* Revenue for three months ended June 30, 2016 totaled $956,486, a 1% decrease from three months ended june 30, 2015. Source text for Eikon: Further company coverage:

Aug 11 2016

BRIEF-Akers Biosciences signs deal for Breathscan Oxichek(tm)

* Akers Biosciences signs distribution agreement for Breathscan Oxichek(tm) Source text for Eikon: Further company coverage:

Jun 27 2016

Earnings vs. Estimates